MetaCap

Medtronic Earnings

NYSE: MDTHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

88.48+0.73 (+0.83%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Medtronic earnings summary

In its most recent report on Sep 3, 2026 (Q1 2027), MDT posted EPS of $1.14. Revenue for the quarter was $9.76 billion. Quarterly EPS is up 40.7% from the same quarter a year earlier.

Across the last 16 reports, MDT shares moved an average of 2.7% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.

Summary generated from market data by MetaCap's automated system. Methodology

MDT earnings history

Medtronic reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Sep 3, 2026—$1.14—-3.4%
Jun 18, 2026—$0.96—+2.1%
Feb 24, 2026—$0.89—-6.9%
Nov 25, 2025—$1.07—-3.8%
Aug 26, 2025—$0.81—+0.1%
Jun 20, 2025—$0.81—-0.4%
Feb 25, 2025—$1.01—+2.7%
Nov 26, 2024—$0.99—-2.9%
Aug 27, 2024—$0.80—+1.5%
Jun 20, 2024—$0.50—-3.6%
Feb 27, 2024—$0.99—+1.8%
Nov 30, 2023—$0.68—-0.8%
Aug 31, 2023—$0.59—-2.6%
Jun 22, 2023—$0.88—+0.7%
Mar 1, 2023—$0.92—-8.0%
Dec 1, 2022—$0.32—-1.3%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related